Black Rock Inc. Anavex Life Sciences Corp. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Black Rock Inc. holds 6,391,472 shares of AVXL stock, worth $77.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,391,472

Previous 6,645,538 3.82%

Holding current value

$77.4 Million

Previous $33.8 Million 20.26%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.39 - $5.02 $861,283 - $1.28 Million	-254,066 Reduced 3.82%	6,391,472 $27 Million
Q1 2024 May 10, 2024	SELL	$4.55 - $6.75 $116,193 - $172,374	-25,537 Reduced 0.38%	6,645,538 $33.8 Million
Q4 2023 Feb 13, 2024	BUY	$5.04 - $9.95 $3.07 Million - $6.07 Million	609,884 Added 10.06%	6,671,075 $62.1 Million
Q3 2023 Nov 13, 2023	BUY	$6.55 - $9.37 $800,560 - $1.15 Million	122,223 Added 2.06%	6,061,191 $39.7 Million
Q2 2023 Aug 11, 2023	BUY	$7.66 - $9.5 $1.54 Million - $1.91 Million	201,318 Added 3.51%	5,938,968 $48.3 Million
Q1 2023 May 12, 2023	BUY	$8.32 - $11.75 $1.33 Million - $1.87 Million	159,491 Added 2.86%	5,737,650 $49.2 Million
Q4 2022 Feb 13, 2023	BUY	$7.65 - $14.43 $2.02 Million - $3.81 Million	263,982 Added 4.97%	5,578,159 $51.7 Million
Q3 2022 Nov 14, 2022	SELL	$8.9 - $12.86 $359,168 - $518,978	-40,356 Reduced 0.75%	5,314,177 $54.8 Million
Q2 2022 Aug 12, 2022	BUY	$7.31 - $12.84 $210,155 - $369,137	28,749 Added 0.54%	5,354,533 $53.6 Million
Q1 2022 May 12, 2022	BUY	$9.74 - $17.69 $614,769 - $1.12 Million	63,118 Added 1.2%	5,325,784 $65.6 Million
Q4 2021 Feb 10, 2022	BUY	$16.88 - $23.31 $14 Million - $19.3 Million	829,565 Added 18.71%	5,262,666 $91.3 Million
Q3 2021 Nov 09, 2021	BUY	$16.82 - $25.75 $2.03 Million - $3.11 Million	120,633 Added 2.8%	4,433,101 $79.6 Million
Q2 2021 Aug 11, 2021	BUY	$10.16 - $28.86 $43.8 Million - $124 Million	4,312,468 New	4,312,468 $98.6 Million

Others Institutions Holding AVXL

# of Institutions

155

Shares Held

27.3M

Call Options Held

515K

Put Options Held

838K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $944M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account